Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 120 entries
Sorted by: Best Match Show Resources per page
Prelithiation Activates Li(Ni0.5Mn0.3Co0.2)O2 for High Capacity and Excellent Cycling Stability.

Nano letters

Wu Z, Ji S, Zheng J, Hu Z, Xiao S, Wei Y, Zhuo Z, Lin Y, Yang W, Xu K, Amine K, Pan F.
PMID: 26182195
Nano Lett. 2015 Aug 12;15(8):5590-6. doi: 10.1021/acs.nanolett.5b02246. Epub 2015 Jul 21.

Transition metal oxide materials Li(NixMnyCoz)O2 (NMC) based on layered structures are expected to replace LiFePO4 in automotive Li-ion batteries because of their higher specific capacity and operating potential. However, the actual usable capacity is much lower than the promised...

Cite
Wu Z, Ji S, Zheng J, et al. Prelithiation Activates Li(Ni0.5Mn0.3Co0.2)O2 for High Capacity and Excellent Cycling Stability. Nano Lett. 2015;15(8):5590-6doi: 10.1021/acs.nanolett.5b02246.
Wu, Z., Ji, S., Zheng, J., Hu, Z., Xiao, S., Wei, Y., Zhuo, Z., Lin, Y., Yang, W., Xu, K., Amine, K., & Pan, F. (2015). Prelithiation Activates Li(Ni0.5Mn0.3Co0.2)O2 for High Capacity and Excellent Cycling Stability. Nano letters, 15(8), 5590-6. https://doi.org/10.1021/acs.nanolett.5b02246
Wu, Zhongzhen, et al. "Prelithiation Activates Li(Ni0.5Mn0.3Co0.2)O2 for High Capacity and Excellent Cycling Stability." Nano letters vol. 15,8 (2015): 5590-6. doi: https://doi.org/10.1021/acs.nanolett.5b02246
Wu Z, Ji S, Zheng J, Hu Z, Xiao S, Wei Y, Zhuo Z, Lin Y, Yang W, Xu K, Amine K, Pan F. Prelithiation Activates Li(Ni0.5Mn0.3Co0.2)O2 for High Capacity and Excellent Cycling Stability. Nano Lett. 2015 Aug 12;15(8):5590-6. doi: 10.1021/acs.nanolett.5b02246. Epub 2015 Jul 21. PMID: 26182195.
Copy Download .nbib Format: NLM
Nanoparticle Uptake: The Phagocyte Problem.

Nano today

Gustafson HH, Holt-Casper D, Grainger DW, Ghandehari H.
PMID: 26640510
Nano Today. 2015 Aug;10(4):487-510. doi: 10.1016/j.nantod.2015.06.006. Epub 2015 Sep 05.

Phagocytes are key cellular participants determining important aspects of host exposure to nanomaterials, initiating clearance, biodistribution and the tenuous balance between host tolerance and adverse nanotoxicity. Macrophages in particular are believed to be among the first and primary cell...

Cite
Gustafson HH, Holt-Casper D, Grainger DW, et al. Nanoparticle Uptake: The Phagocyte Problem. Nano Today. 2015;10(4):487-510doi: 10.1016/j.nantod.2015.06.006.
Gustafson, H. H., Holt-Casper, D., Grainger, D. W., & Ghandehari, H. (2015). Nanoparticle Uptake: The Phagocyte Problem. Nano today, 10(4), 487-510. https://doi.org/10.1016/j.nantod.2015.06.006
Gustafson, Heather Herd, et al. "Nanoparticle Uptake: The Phagocyte Problem." Nano today vol. 10,4 (2015): 487-510. doi: https://doi.org/10.1016/j.nantod.2015.06.006
Gustafson HH, Holt-Casper D, Grainger DW, Ghandehari H. Nanoparticle Uptake: The Phagocyte Problem. Nano Today. 2015 Aug;10(4):487-510. doi: 10.1016/j.nantod.2015.06.006. Epub 2015 Sep 05. PMID: 26640510; PMCID: PMC4666556.
Copy Download .nbib Format: NLM
Multifunctional nanoscale strategies for enhancing and monitoring blood vessel regeneration.

Nano today

Chung E, Ricles LM, Stowers RS, Nam SY, Emelianov SY, Suggs LJ.
PMID: 28989343
Nano Today. 2012 Dec;7(6):514-531. doi: 10.1016/j.nantod.2012.10.007. Epub 2012 Nov 17.

Nanomedicine has great potential in biomedical applications, and specifically in regenerative medicine and vascular tissue engineering. Designing nanometer-sized therapeutic and diagnostic devices for tissue engineering applications is critical because cells experience and respond to stimuli on this spatial scale....

Cite
Chung E, Ricles LM, Stowers RS, et al. Multifunctional nanoscale strategies for enhancing and monitoring blood vessel regeneration. Nano Today. 2012;7(6):514-531doi: 10.1016/j.nantod.2012.10.007.
Chung, E., Ricles, L. M., Stowers, R. S., Nam, S. Y., Emelianov, S. Y., & Suggs, L. J. (2012). Multifunctional nanoscale strategies for enhancing and monitoring blood vessel regeneration. Nano today, 7(6), 514-531. https://doi.org/10.1016/j.nantod.2012.10.007
Chung, Eunna, et al. "Multifunctional nanoscale strategies for enhancing and monitoring blood vessel regeneration." Nano today vol. 7,6 (2012): 514-531. doi: https://doi.org/10.1016/j.nantod.2012.10.007
Chung E, Ricles LM, Stowers RS, Nam SY, Emelianov SY, Suggs LJ. Multifunctional nanoscale strategies for enhancing and monitoring blood vessel regeneration. Nano Today. 2012 Dec;7(6):514-531. doi: 10.1016/j.nantod.2012.10.007. Epub 2012 Nov 17. PMID: 28989343; PMCID: PMC5630157.
Copy Download .nbib Format: NLM
Enhancing Cell therapies from the Outside In: Cell Surface Engineering Using Synthetic Nanomaterials.

Nano today

Stephan MT, Irvine DJ.
PMID: 21826117
Nano Today. 2011 Jun 01;6(3):309-325. doi: 10.1016/j.nantod.2011.04.001.

Therapeutic treatments based on the injection of living cells are in clinical use and preclinical development for diseases ranging from cancer to cardiovascular disease to diabetes. To enhance the function of therapeutic cells, a variety of chemical and materials...

Cite
Stephan MT, Irvine DJ. Enhancing Cell therapies from the Outside In: Cell Surface Engineering Using Synthetic Nanomaterials. Nano Today. 2011;6(3):309-325doi: 10.1016/j.nantod.2011.04.001.
Stephan, M. T., & Irvine, D. J. (2011). Enhancing Cell therapies from the Outside In: Cell Surface Engineering Using Synthetic Nanomaterials. Nano today, 6(3), 309-325. https://doi.org/10.1016/j.nantod.2011.04.001
Stephan, Matthias T, and Irvine, Darrell J. "Enhancing Cell therapies from the Outside In: Cell Surface Engineering Using Synthetic Nanomaterials." Nano today vol. 6,3 (2011): 309-325. doi: https://doi.org/10.1016/j.nantod.2011.04.001
Stephan MT, Irvine DJ. Enhancing Cell therapies from the Outside In: Cell Surface Engineering Using Synthetic Nanomaterials. Nano Today. 2011 Jun 01;6(3):309-325. doi: 10.1016/j.nantod.2011.04.001. PMID: 21826117; PMCID: PMC3148657.
Copy Download .nbib Format: NLM
Ultrastable synergistic tetravalent RNA nanoparticles for targeting to cancers.

Nano today

Haque F, Shu D, Shu Y, Shlyakhtenko LS, Rychahou PG, Evers BM, Guo P.
PMID: 23024702
Nano Today. 2012 Aug;7(4):245-257. doi: 10.1016/j.nantod.2012.06.010.

One of the advantages of nanotechnology is the feasibility to construct therapeutic particles carrying multiple therapeutics with defined structure and stoichiometry. The field of RNA nanotechnology is emerging. However, controlled assembly of stable RNA nanoparticles with multiple functionalities which...

Cite
Haque F, Shu D, Shu Y, et al. Ultrastable synergistic tetravalent RNA nanoparticles for targeting to cancers. Nano Today. 2012;7(4):245-257doi: 10.1016/j.nantod.2012.06.010.
Haque, F., Shu, D., Shu, Y., Shlyakhtenko, L. S., Rychahou, P. G., Evers, B. M., & Guo, P. (2012). Ultrastable synergistic tetravalent RNA nanoparticles for targeting to cancers. Nano today, 7(4), 245-257. https://doi.org/10.1016/j.nantod.2012.06.010
Haque, Farzin, et al. "Ultrastable synergistic tetravalent RNA nanoparticles for targeting to cancers." Nano today vol. 7,4 (2012): 245-257. doi: https://doi.org/10.1016/j.nantod.2012.06.010
Haque F, Shu D, Shu Y, Shlyakhtenko LS, Rychahou PG, Evers BM, Guo P. Ultrastable synergistic tetravalent RNA nanoparticles for targeting to cancers. Nano Today. 2012 Aug;7(4):245-257. doi: 10.1016/j.nantod.2012.06.010. PMID: 23024702; PMCID: PMC3458310.
Copy Download .nbib Format: NLM
Point-of-care diagnostics for infectious diseases: From methods to devices.

Nano today

Wang C, Liu M, Wang Z, Li S, Deng Y, He N.
PMID: 33584847
Nano Today. 2021 Apr;37:101092. doi: 10.1016/j.nantod.2021.101092. Epub 2021 Feb 06.

The current widespread of COVID-19 all over the world, which is caused by SARS-CoV-2 virus, has again emphasized the importance of development of point-of-care (POC) diagnostics for timely prevention and control of the pandemic. Compared with labor- and time-consuming...

Cite
Wang C, Liu M, Wang Z, et al. Point-of-care diagnostics for infectious diseases: From methods to devices. Nano Today. 2021;37:101092doi: 10.1016/j.nantod.2021.101092.
Wang, C., Liu, M., Wang, Z., Li, S., Deng, Y., & He, N. (2021). Point-of-care diagnostics for infectious diseases: From methods to devices. Nano today, 37101092. https://doi.org/10.1016/j.nantod.2021.101092
Wang, Chao, et al. "Point-of-care diagnostics for infectious diseases: From methods to devices." Nano today vol. 37 (2021): 101092. doi: https://doi.org/10.1016/j.nantod.2021.101092
Wang C, Liu M, Wang Z, Li S, Deng Y, He N. Point-of-care diagnostics for infectious diseases: From methods to devices. Nano Today. 2021 Apr;37:101092. doi: 10.1016/j.nantod.2021.101092. Epub 2021 Feb 06. PMID: 33584847; PMCID: PMC7864790.
Copy Download .nbib Format: NLM
Antibody cooperative adsorption onto AuNPs and its exploitation to force natural killer cells to kill HIV-infected T cells.

Nano today

Astorga-Gamaza A, Vitali M, Borrajo ML, Suárez-López R, Jaime C, Bastus N, Serra-Peinado C, Luque-Ballesteros L, Blanch-Lombarte O, Prado JG, Lorente J, Pumarola F, Pellicer M, Falcó V, Genescà M, Puntes V, Buzon MJ.
PMID: 34394703
Nano Today. 2021 Feb;36. doi: 10.1016/j.nantod.2020.101056. Epub 2020 Dec 20.

HIV represents a persistent infection which negatively alters the immune system. New tools to reinvigorate different immune cell populations to impact HIV are needed. Herein, a novel nanotool for the specific enhancement of the natural killer (NK) immune response...

Cite
Astorga-Gamaza A, Vitali M, Borrajo ML, et al. Antibody cooperative adsorption onto AuNPs and its exploitation to force natural killer cells to kill HIV-infected T cells. Nano Today. 2020;36doi: 10.1016/j.nantod.2020.101056.
Astorga-Gamaza, A., Vitali, M., Borrajo, M. L., Suárez-López, R., Jaime, C., Bastus, N., Serra-Peinado, C., Luque-Ballesteros, L., Blanch-Lombarte, O., Prado, J. G., Lorente, J., Pumarola, F., Pellicer, M., Falcó, V., Genescà, M., Puntes, V., & Buzon, M. J. (2021). Antibody cooperative adsorption onto AuNPs and its exploitation to force natural killer cells to kill HIV-infected T cells. Nano today, 36. https://doi.org/10.1016/j.nantod.2020.101056
Astorga-Gamaza, Antonio, et al. "Antibody cooperative adsorption onto AuNPs and its exploitation to force natural killer cells to kill HIV-infected T cells." Nano today vol. 36 (2021). doi: https://doi.org/10.1016/j.nantod.2020.101056
Astorga-Gamaza A, Vitali M, Borrajo ML, Suárez-López R, Jaime C, Bastus N, Serra-Peinado C, Luque-Ballesteros L, Blanch-Lombarte O, Prado JG, Lorente J, Pumarola F, Pellicer M, Falcó V, Genescà M, Puntes V, Buzon MJ. Antibody cooperative adsorption onto AuNPs and its exploitation to force natural killer cells to kill HIV-infected T cells. Nano Today. 2021 Feb;36. doi: 10.1016/j.nantod.2020.101056. Epub 2020 Dec 20. PMID: 34394703; PMCID: PMC8360327.
Copy Download .nbib Format: NLM
Platelet membrane and stem cell exosome hybrid enhances cellular uptake and targeting to heart injury.

Nano today

Hu S, Wang X, Li Z, Zhu D, Cores J, Wang Z, Li J, Mei X, Cheng X, Su T, Cheng K.
PMID: 34306170
Nano Today. 2021 Aug;39. doi: 10.1016/j.nantod.2021.101210. Epub 2021 Jun 08.

Exosomes from mesenchymal stem cells have been largely studied as therapeutics to treat myocardial infarctions. However, exosomes injected for therapeutic purposes face a number of challenges, including competition from exosomes already in circulation, and the internalization/clearance by the mononuclear...

Cite
Hu S, Wang X, Li Z, et al. Platelet membrane and stem cell exosome hybrid enhances cellular uptake and targeting to heart injury. Nano Today. 2021;39doi: 10.1016/j.nantod.2021.101210.
Hu, S., Wang, X., Li, Z., Zhu, D., Cores, J., Wang, Z., Li, J., Mei, X., Cheng, X., Su, T., & Cheng, K. (2021). Platelet membrane and stem cell exosome hybrid enhances cellular uptake and targeting to heart injury. Nano today, 39. https://doi.org/10.1016/j.nantod.2021.101210
Hu, Shiqi, et al. "Platelet membrane and stem cell exosome hybrid enhances cellular uptake and targeting to heart injury." Nano today vol. 39 (2021). doi: https://doi.org/10.1016/j.nantod.2021.101210
Hu S, Wang X, Li Z, Zhu D, Cores J, Wang Z, Li J, Mei X, Cheng X, Su T, Cheng K. Platelet membrane and stem cell exosome hybrid enhances cellular uptake and targeting to heart injury. Nano Today. 2021 Aug;39. doi: 10.1016/j.nantod.2021.101210. Epub 2021 Jun 08. PMID: 34306170; PMCID: PMC8294084.
Copy Download .nbib Format: NLM
Nanotechnology for Pain Management: Current and Future Therapeutic Interventions.

Nano today

Bhansali D, Teng SL, Lee CS, Schmidt BL, Bunnett NW, Leong KW.
PMID: 34899962
Nano Today. 2021 Aug;39. doi: 10.1016/j.nantod.2021.101223. Epub 2021 Jun 19.

Pain is one of the most common medical conditions and affects more Americans than diabetes, heart disease, and cancer combined. Current pain treatments mainly rely on opioid analgesics and remain unsatisfactory. The life-threatening side effects and addictive properties of...

Cite
Bhansali D, Teng SL, Lee CS, et al. Nanotechnology for Pain Management: Current and Future Therapeutic Interventions. Nano Today. 2021;39doi: 10.1016/j.nantod.2021.101223.
Bhansali, D., Teng, S. L., Lee, C. S., Schmidt, B. L., Bunnett, N. W., & Leong, K. W. (2021). Nanotechnology for Pain Management: Current and Future Therapeutic Interventions. Nano today, 39. https://doi.org/10.1016/j.nantod.2021.101223
Bhansali, Divya, et al. "Nanotechnology for Pain Management: Current and Future Therapeutic Interventions." Nano today vol. 39 (2021). doi: https://doi.org/10.1016/j.nantod.2021.101223
Bhansali D, Teng SL, Lee CS, Schmidt BL, Bunnett NW, Leong KW. Nanotechnology for Pain Management: Current and Future Therapeutic Interventions. Nano Today. 2021 Aug;39. doi: 10.1016/j.nantod.2021.101223. Epub 2021 Jun 19. PMID: 34899962; PMCID: PMC8654201.
Copy Download .nbib Format: NLM
TiO.

Nano today

Wang D, Zhang B, Ding H, Liu D, Xiang J, Gao XJ, Chen X, Li Z, Yang L, Duan H, Zheng J, Liu Z, Jiang B, Liu Y, Xie N, Zhang H, Yan X, Fan K, Nie G.
PMID: 34249143
Nano Today. 2021 Oct;40:101243. doi: 10.1016/j.nantod.2021.101243. Epub 2021 Jul 07.

The outbreak of SARS-coronavirus 2 (SARS-CoV2) has become a global health emergency. Although enormous efforts have been made, there is still no effective treatment against the new virus. Herein, a TiO

Cite
Wang D, Zhang B, Ding H, et al. TiO. Nano Today. 2021;40:101243doi: 10.1016/j.nantod.2021.101243.
Wang, D., Zhang, B., Ding, H., Liu, D., Xiang, J., Gao, X. J., Chen, X., Li, Z., Yang, L., Duan, H., Zheng, J., Liu, Z., Jiang, B., Liu, Y., Xie, N., Zhang, H., Yan, X., Fan, K., & Nie, G. (2021). TiO. Nano today, 40101243. https://doi.org/10.1016/j.nantod.2021.101243
Wang, Daji, et al. "TiO." Nano today vol. 40 (2021): 101243. doi: https://doi.org/10.1016/j.nantod.2021.101243
Wang D, Zhang B, Ding H, Liu D, Xiang J, Gao XJ, Chen X, Li Z, Yang L, Duan H, Zheng J, Liu Z, Jiang B, Liu Y, Xie N, Zhang H, Yan X, Fan K, Nie G. TiO. Nano Today. 2021 Oct;40:101243. doi: 10.1016/j.nantod.2021.101243. Epub 2021 Jul 07. PMID: 34249143; PMCID: PMC8260506.
Copy Download .nbib Format: NLM
What NIR photodynamic activation offers molecular targeted nanomedicines: Perspectives into the conundrum of tumor specificity and selectivity.

Nano today

Bhandari C, Guirguis M, Savan NA, Shrivastava N, Oliveira S, Hasan T, Obaid G.
PMID: 33552231
Nano Today. 2021 Feb;36. doi: 10.1016/j.nantod.2020.101052. Epub 2020 Dec 16.

Near infrared (NIR) photodynamic activation is playing increasingly critical roles in cutting-edge anti-cancer nanomedicines, which include spatiotemporal control over induction of therapy, photodynamic priming, and phototriggered immunotherapy. Molecular targeted photonanomedicines (mt-PNMs) are tumor-specific nanoscale drug delivery systems, which capitalize...

Cite
Bhandari C, Guirguis M, Savan NA, et al. What NIR photodynamic activation offers molecular targeted nanomedicines: Perspectives into the conundrum of tumor specificity and selectivity. Nano Today. 2020;36doi: 10.1016/j.nantod.2020.101052.
Bhandari, C., Guirguis, M., Savan, N. A., Shrivastava, N., Oliveira, S., Hasan, T., & Obaid, G. (2021). What NIR photodynamic activation offers molecular targeted nanomedicines: Perspectives into the conundrum of tumor specificity and selectivity. Nano today, 36. https://doi.org/10.1016/j.nantod.2020.101052
Bhandari, Chanda, et al. "What NIR photodynamic activation offers molecular targeted nanomedicines: Perspectives into the conundrum of tumor specificity and selectivity." Nano today vol. 36 (2021). doi: https://doi.org/10.1016/j.nantod.2020.101052
Bhandari C, Guirguis M, Savan NA, Shrivastava N, Oliveira S, Hasan T, Obaid G. What NIR photodynamic activation offers molecular targeted nanomedicines: Perspectives into the conundrum of tumor specificity and selectivity. Nano Today. 2021 Feb;36. doi: 10.1016/j.nantod.2020.101052. Epub 2020 Dec 16. PMID: 33552231; PMCID: PMC7864390.
Copy Download .nbib Format: NLM
Lateral size of graphene oxide determines differential cellular uptake and cell death pathways in Kupffer cells, LSECs, and hepatocytes.

Nano today

Li J, Wang X, Mei KC, Chang CH, Jiang J, Liu X, Liu Q, Guiney LM, Hersam MC, Liao YP, Meng H, Xia T.
PMID: 34055032
Nano Today. 2021 Apr;37. doi: 10.1016/j.nantod.2020.101061. Epub 2020 Dec 24.

As a representative two-dimensional (2D) nanomaterial, graphene oxide (GO) has shown high potential in many applications due to its large surface area, high flexibility, and excellent dispersibility in aqueous solutions. These properties make GO an ideal candidate for bio-imaging,...

Cite
Li J, Wang X, Mei KC, et al. Lateral size of graphene oxide determines differential cellular uptake and cell death pathways in Kupffer cells, LSECs, and hepatocytes. Nano Today. 2020;37doi: 10.1016/j.nantod.2020.101061.
Li, J., Wang, X., Mei, K. C., Chang, C. H., Jiang, J., Liu, X., Liu, Q., Guiney, L. M., Hersam, M. C., Liao, Y. P., Meng, H., & Xia, T. (2021). Lateral size of graphene oxide determines differential cellular uptake and cell death pathways in Kupffer cells, LSECs, and hepatocytes. Nano today, 37. https://doi.org/10.1016/j.nantod.2020.101061
Li, Jiulong, et al. "Lateral size of graphene oxide determines differential cellular uptake and cell death pathways in Kupffer cells, LSECs, and hepatocytes." Nano today vol. 37 (2021). doi: https://doi.org/10.1016/j.nantod.2020.101061
Li J, Wang X, Mei KC, Chang CH, Jiang J, Liu X, Liu Q, Guiney LM, Hersam MC, Liao YP, Meng H, Xia T. Lateral size of graphene oxide determines differential cellular uptake and cell death pathways in Kupffer cells, LSECs, and hepatocytes. Nano Today. 2021 Apr;37. doi: 10.1016/j.nantod.2020.101061. Epub 2020 Dec 24. PMID: 34055032; PMCID: PMC8153408.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 120 entries